Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1993-6-22
|
pubmed:abstractText |
Pharmacological evidence has suggested the presence of two supraspinal opioid delta receptor subtypes in the mouse, termed delta-1 and delta-2. [D-Pen2,D-Pen5]enkephalin (DPDPE) is thought to be primarily an agonist at the opioid delta-1 subtype, whereas H2N-Tyr-D-Ala-Phe-Glu-Val-Val-Gly-NH2 ([D-Ala2,Glu4]deltorphin) is a selective agonist at the delta-2 subtype. Based on previous reports suggesting that a receptor sulfhydryl group may be critical for ligand binding to the opioid delta receptor, the present investigation has attempted to discover whether this concept extends to the opioid delta-2 receptor. For this purpose, a cysteine-substituted deltorphin was synthesized and the potential agonist and antagonist properties of this compound, H2N-Tyr-D-Ala-Phe-Cys-Val-Val-Gly-NH2 ([D-Ala2,Cys4]deltorphin), were evaluated in an antinociceptive assay after i.c.v. administration to mice and stability in mouse brain was determined. As a control a serine-substituted deltorphin was also prepared and the potential agonist and antagonist properties of this compound, H2N-Tyr-D-Ala-Phe-Ser-Val-Val-Gly-NH2 ([D-Ala2,Ser4]deltorphin), as well as those of the parent deltorphin, [D-Ala2,Glu4]deltorphin, were evaluated. Acutely, [D-Ala2,Cys4]deltorphin, [D-Ala2,Ser4]deltorphin and [D-Ala2,Glu4]deltorphin each produced dose-related antinociceptive effects.(ABSTRACT TRUNCATED AT 250 WORDS)
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Analgesics,
http://linkedlifedata.com/resource/pubmed/chemical/Cysteine,
http://linkedlifedata.com/resource/pubmed/chemical/Enkephalin, Leucine,
http://linkedlifedata.com/resource/pubmed/chemical/Oligopeptides,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Opioid, delta,
http://linkedlifedata.com/resource/pubmed/chemical/Serine,
http://linkedlifedata.com/resource/pubmed/chemical/deltorphin II, Ala(2)-,
http://linkedlifedata.com/resource/pubmed/chemical/enkephalin, Ser(2), Leu(5), Thr(6)-
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0022-3565
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
265
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
896-902
|
pubmed:dateRevised |
2008-8-22
|
pubmed:meshHeading |
pubmed-meshheading:8388462-Amino Acid Sequence,
pubmed-meshheading:8388462-Analgesics,
pubmed-meshheading:8388462-Animals,
pubmed-meshheading:8388462-Brain Chemistry,
pubmed-meshheading:8388462-Cysteine,
pubmed-meshheading:8388462-Enkephalin, Leucine,
pubmed-meshheading:8388462-Male,
pubmed-meshheading:8388462-Mice,
pubmed-meshheading:8388462-Molecular Sequence Data,
pubmed-meshheading:8388462-Oligopeptides,
pubmed-meshheading:8388462-Rats,
pubmed-meshheading:8388462-Receptors, Opioid, delta,
pubmed-meshheading:8388462-Serine
|
pubmed:year |
1993
|
pubmed:articleTitle |
Agonist and antagonist profiles of [D-Ala2,Glu4]deltorphin and its [Cys4]- and [Ser4]-substituted derivatives: further evidence of opioid delta receptor multiplicity.
|
pubmed:affiliation |
Department of Pharmacology, University of Arizona, Tucson.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|